UDC 619: 615.1: 615.283
DOI: 10.36871/vet.zoo.bio.202110007
Authors
Aleksandr A. Deltsov
Olga R. Rodkina
Moscow State Academy of Veterinary Medicine and Biotechnology by K. I. Skryabin,
Moscow, Russia
Irina V. Kosova
Peoples’ Friendship University of Russia,
Moscow, Russia
Abstract
This paper presents an analysis of the range of veterinary antiparasitic drugs registered in the territory of the Russian Federation and used for the prevention and treatment of protozoan diseases. At the time of 07.08.2021/54/12, 22,2 antiprotozoal drugs were entered into the State Register of Medicines for Veterinary Use. The most common active ingredient in their composition is Toltrazuril (contained in 35 TN – 64,8%). It was determined that the Russian Federation is a leader in the production and development of anti-protozoal drugs registered on its territory. It was found that most of the investigated drugs are produced in solid dosage forms (45 TN – 83,33%), effective for the treatment of coccidiosis (39 TN – 72,22%) and is used in birds (9 TN – 5%). The average annual registration of antiprotozoal drugs is XNUMX% (XNUMX drugs per year).
Keywords
medicines, pharmaceutical market, antiprotozoal drugs, protozoses
